어큐레이 (ARAY) 주가

어큐레이(ARAY)는 NASDAQ에 상장된 Healthcare · Medical Devices 기업입니다. 현재가 $0.28 (+0.98%), 시가총액 $0.03B, 52주 범위 $0.27 ~ $1.85.

Accuray Incorporated engages in the design, development, manufacture, and sale of radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. The company offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. It also provides the TomoTherapy platform, including the Radixact System, which allows for integrated radiatio

핵심 지표

• 현재가: $0.28 (+0.98%)
• 시가총액: $0.03B
• 52주 최저~최고: $0.27 ~ $1.85
• 섹터: Healthcare
• 산업: Medical Devices
• 거래소: NASDAQ

어큐레이의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackQuant에서 실시간으로 확인할 수 있습니다.

어큐레이 재무 요약

애널리스트 전망

• 투자의견 컨센서스: 4.75

핵심 재무비율 · 수익성 · 성장성

• PBR (주가순자산비율): 0.77
• 순이익률: -0.11%
• 영업이익률: -0.02%

자주 묻는 질문